
Our Products & Programs
Innovative solutions, proven impact
We are fiercely dedicated to our mission of improving women’s health worldwide. Our launched products address pressing health concerns of women, providing them with the products they need to live healthier, more fulfilled lives.
Our Products
Medicines360 has deep expertise developing, launching, and implementing life-changing health innovations for women. Our products are currently being used by women around the globe.
Please click on the product-specific links below to see where each product is approved and available for distribution and use.
(Levonorgestrel-Releasing Intrauterine System) 52mg
Liletta® is an intrauterine system, or IUS, also known as an IUD, or intrauterine device. Liletta is available in the United States through our commercial partner.
(Levonorgestrel-Releasing Intrauterine System) 52mg
Avibela™ is our IUD’s brand name in low- and middle-income countries and is available with either a two-handed or single-handed inserter. Medicines360, through its wholly owned subsidiary Impact RH360, offers AVIBELA at an affordable price in Africa, South and Southeast Asia, Central America, and the Caribbean. AVIBELA is not available in the US.
Our Programs
We partner with leading healthcare organizations who, like us, are champions for women’s health and who offer a range of affordable, reliable women’s health products. Through healthcare provider education efforts with our on-the-ground team, we enable our partners to reach more women across the US and provide more comprehensive services, delivering greater impact.
Our Accomplishments
Our accomplishments
fuel our vision
Medicines360 was founded by women in 2009 to break barriers to access, and in the process, change women’s lives for the better.
We started with a goal of increasing women’s access to an innovative, highly effective contraception option — the hormonal IUD — by making it affordable while demonstrating that it is a safe and effective option for more women than had been previously recognized.
Development of our hormonal IUD had a significant catalytic effect on US and global access for women, proving that a mission-driven organization can have a profound effect on market dynamics.
Since our founding, we have made important strides in shaping women’s health in the US and globally:
Clinical Studies
Largest IUD Study
Conducted the United States’ largest and most diverse Phase 3 clinical study ever on a hormonal intrauterine device (IUD).
Lowering Costs
Saved over $120 Million
Saved the US public healthcare system over $120 million (estimate as of 2025).
Innovative Approach
CATALYZED IUD ACCESS
Initiated studies to extend the duration of use for the IUD and to show that same-day IUD insertion was feasible, reducing the burden of clinic visits.
Public Health
Served 4,000 clinics
Served 4,000 safety net clinics and hospitals throughout the US who provide care to underserved women.
Expanding Access
IUDs for 1.8M women
Made our hormonal IUD available to nearly 2 million women throughout the United States, with more than half a million distributed to women seen at safety net clinics and hospitals.
Global Program
Global Access
Supplied more than 65,000 hormonal IUDs to global procurement agencies and other partners at low access pricing, for distribution to women across Africa, Central America, and the Caribbean.
Women’s lives impacted
Championing women’s health worldwide

Access
to Care
Our creative approaches to solving consequential women’s health issues are designed to ensure that all women can access life-changing products from day one.

GLOBAL
Reach
We partner with global health organizations, nonprofits, and governments to ensure we reach women in low- and middle-income countries.

Expanding Impact
Our reach continues to grow
Expanding the scope and scale of our health innovations
By shining a spotlight on the urgent need for innovation in women’s health, by championing groundbreaking research and advocating for access to care, Medicines360 has successfully mobilized industry leaders, policymakers, and donor organizations into creating meaningful change. Our advocacy efforts have led to increased investment in research, development, and access to life-changing products. By fostering collaborations and partnerships, we’ve accelerated the pace of innovation and brought groundbreaking solutions to women worldwide.
Our work is not just about advancing science; it’s about empowering individuals and communities. By catalyzing industry-wide shifts, we’re creating a future where every woman has access to an improved quality of life.